AU2064899A - Methods and compositions for desensitisation - Google Patents

Methods and compositions for desensitisation Download PDF

Info

Publication number
AU2064899A
AU2064899A AU20648/99A AU2064899A AU2064899A AU 2064899 A AU2064899 A AU 2064899A AU 20648/99 A AU20648/99 A AU 20648/99A AU 2064899 A AU2064899 A AU 2064899A AU 2064899 A AU2064899 A AU 2064899A
Authority
AU
Australia
Prior art keywords
peptide
peptides
mhc class
allergen
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20648/99A
Other languages
English (en)
Inventor
Anthony Barrington Kay
Mark Larche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niox Healthcare Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9800445.0A external-priority patent/GB9800445D0/en
Priority claimed from GBGB9820474.6A external-priority patent/GB9820474D0/en
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of AU2064899A publication Critical patent/AU2064899A/en
Priority to AU2003203987A priority Critical patent/AU2003203987B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU20648/99A 1998-01-09 1999-01-11 Methods and compositions for desensitisation Abandoned AU2064899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003203987A AU2003203987B2 (en) 1998-01-09 2003-05-05 Methods and compositions for desensitisation

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9800445 1998-01-09
GBGB9800445.0A GB9800445D0 (en) 1998-01-09 1998-01-09 Method for desensitisation
GBGB9820474.6A GB9820474D0 (en) 1998-09-21 1998-09-21 Method for desensitisation
GB9820474 1998-09-21
PCT/GB1999/000080 WO1999034826A1 (en) 1998-01-09 1999-01-11 Methods and compositions for desensitisation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003203987A Division AU2003203987B2 (en) 1998-01-09 2003-05-05 Methods and compositions for desensitisation

Publications (1)

Publication Number Publication Date
AU2064899A true AU2064899A (en) 1999-07-26

Family

ID=26312916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20648/99A Abandoned AU2064899A (en) 1998-01-09 1999-01-11 Methods and compositions for desensitisation

Country Status (7)

Country Link
US (1) US20040265342A1 (cg-RX-API-DMAC7.html)
EP (1) EP1044019A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002500198A (cg-RX-API-DMAC7.html)
AU (1) AU2064899A (cg-RX-API-DMAC7.html)
CA (1) CA2317724A1 (cg-RX-API-DMAC7.html)
GB (1) GB2348808B (cg-RX-API-DMAC7.html)
WO (1) WO1999034826A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69940805D1 (de) 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
AUPQ884500A0 (en) * 2000-07-18 2000-08-10 National University Of Singapore, The Novel therapeutic molecules and uses therefor - III
US6572859B1 (en) 1999-10-29 2003-06-03 Pharmacia Diagnostics Ab Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
EP2258852A1 (en) * 2000-04-28 2010-12-08 Novozymes A/S Lipolytic enzyme variant
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
AUPR779201A0 (en) * 2001-09-20 2001-10-11 University Of Melbourne, The Immunotherapeutic and immunoprophylactic reagents
DE60229979D1 (cg-RX-API-DMAC7.html) * 2001-12-05 2009-01-02 Circassia Ltd
SE0200946D0 (sv) * 2002-03-27 2002-03-27 Pharmacia Diagnostics Ab Novel Allergen
CN100509844C (zh) * 2002-08-19 2009-07-08 默克专利股份公司 来自梯牧草的主要过敏原Phl p1的变异体
EP1403280B1 (en) * 2002-09-27 2005-08-31 BIOMAY Produktions- und Handels- Aktiengesellschaft Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
EP2001515A2 (en) * 2006-03-30 2008-12-17 The Regents of the University of California Ige directed dna vaccination
EP1958645A1 (en) * 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
AU2013202871B2 (en) * 2007-06-01 2015-10-22 Circassia Limited Vaccine peptide combinations against cat allergy
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022155A2 (en) 2007-08-15 2009-02-19 Circassia Limited Peptide with reduced dimer formation
US20110124683A1 (en) * 2007-11-13 2011-05-26 Oxagen Limited Use of CRTH2 Antagonist Compounds
DK2153841T4 (en) 2008-08-15 2016-02-15 Circassia Ltd Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
AU2015227499B2 (en) * 2008-11-28 2017-06-22 Circassia Limited Compositions with reduced dimer formation
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
BRPI1008802A2 (pt) 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição
WO2011085783A1 (de) * 2010-01-14 2011-07-21 Merck Patent Gmbh VARIANTEN DER GRUPPE 5-ALLERGENE DER SÜßGRÄSER MIT REDUZIERTER ALLERGENITÄT DURCH MUTAGENESE VON PROLINRESTEN
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
CN118078979A (zh) 2011-04-29 2024-05-28 西莱克塔生物科技公司 用于降低针对治疗性蛋白的免疫应答的致耐受性合成纳米载体
US11421006B2 (en) 2012-05-03 2022-08-23 La Jolla Institute For Allergy And Immunology T cell epitopes from Cockroach and methods of making and using same
DK2914286T3 (da) 2012-10-30 2021-11-08 Aravax Pty Ltd Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf
US10434088B2 (en) 2013-05-03 2019-10-08 Selecta Biosciences, Inc. Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
JP7007534B2 (ja) 2013-09-25 2022-01-24 アラヴァックス ピーティーワイ リミテッド 新規免疫療法組成物およびその使用
WO2016037165A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
CN108265057B (zh) * 2016-12-31 2019-10-18 江苏众红生物工程创药研究院有限公司 一种重组户尘螨2类变应原蛋白及其制备方法和应用
CN108265059B (zh) * 2016-12-31 2021-01-05 江苏众红生物工程创药研究院有限公司 一种重组粉尘螨2类变应原蛋白及其制备方法与应用
CA3055936A1 (en) 2017-03-11 2018-09-20 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US6180368B1 (en) * 1988-03-23 2001-01-30 University Of Melbourne Ryegrass pollen allergen
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
WO1992011859A1 (en) * 1991-01-08 1992-07-23 Immulogic Pharmaceutical Corporation Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite)
FR2715538B1 (fr) * 1994-02-01 1996-04-26 Roquette Freres Composition de chewing-gum présentant une qualité organoleptique améliorée et procédé permettant de préparer un tel chewing-gum.
AU2238395A (en) * 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
EP0923940B1 (en) * 1996-03-10 2008-09-03 Meiji Dairies Corporation Peptide-based immunotherapeutic agent for allergic diseases
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5

Also Published As

Publication number Publication date
EP1044019A1 (en) 2000-10-18
GB0016438D0 (en) 2000-08-23
JP2002500198A (ja) 2002-01-08
WO1999034826A1 (en) 1999-07-15
GB2348808A (en) 2000-10-18
CA2317724A1 (en) 1999-07-15
US20040265342A1 (en) 2004-12-30
GB2348808B (en) 2003-03-19

Similar Documents

Publication Publication Date Title
US20040265342A1 (en) Methods and compositions for desensitisation
US8652485B2 (en) Peptide for vaccine
AU2008256524B2 (en) Vaccine peptide combinations against cat allergy
JP5926198B2 (ja) カバノキアレルギーに対するワクチン用ペプチド
AU2003203987B2 (en) Methods and compositions for desensitisation
AU2013203568B2 (en) Peptides for desensibilization against allergens
HK1163523A (en) Vaccine peptide combinations against cat allergy
HK1132935B (en) Vaccine peptide combinations against cat allergy
HK1132194B (en) Peptides for desensibilization against allergens
HK1164713A (en) Vaccine peptide combinations against cat allergy

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted